Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Efficacy and Mechanisms of GLN Dipeptide in the SICU

Phase 3

Completed

Conditions: Critical Illness

Interventions: Drug: Glutamine dipeptide with 15% Clinisol
Drug: 15% Clinisol

First Posted Date: 2005-11-04

Last Posted Date: 2018-01-23

Lead Sponsor: Emory University

Target Recruit Count: 150

Registration Number: NCT00248638

Locations: 🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States
🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
The Miriam Hospital/Brown University, Providence, Rhode Island, United States

and more 2 locations

Markers of Oxidative Stress Present in Left Atrial Appendage Tissue in Patients With Atrial Fibrillation

Terminated

Conditions: Atrial Fibrillation
Atrial Flutter
Inflammation

First Posted Date: 2005-10-25

Last Posted Date: 2013-09-27

Lead Sponsor: Emory University

Target Recruit Count: 23

Registration Number: NCT00243802

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development

Recruiting

Conditions: Tetralogy of Fallot
Congenital Heart Disease

First Posted Date: 2005-10-25

Last Posted Date: 2025-06-15

Lead Sponsor: Emory University

Target Recruit Count: 600

Registration Number: NCT00243776

Locations: 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States

Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer

Phase 4

Completed

Conditions: Stomach Ulcer

Interventions: Drug: Prevacid

First Posted Date: 2005-10-17

Last Posted Date: 2013-07-31

Lead Sponsor: Emory University

Target Recruit Count: 30

Registration Number: NCT00239551

Locations: 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States

Efficacy Study of the OV-Watch™ Personal Fertility Monitor for Women Using Clomiphene Citrate.

Completed

Conditions: Infertility
Anovulation
Polycystic Ovary Syndrome

First Posted Date: 2005-10-17

Last Posted Date: 2007-04-17

Lead Sponsor: Emory University

Target Recruit Count: 40

Registration Number: NCT00239603

Locations: 🇺🇸
Emory Reproductive Center, Crawford Long Hospital, Atlanta, Georgia, United States

A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.

Phase 4

Conditions: Asthma

First Posted Date: 2005-10-12

Last Posted Date: 2011-03-16

Lead Sponsor: Emory University

Target Recruit Count: 100

Registration Number: NCT00237068

Locations: 🇺🇸
Emory Children's Center, Atlanta, Georgia, United States
🇺🇸
Children's Center for Digestive Healthcare, Atlanta, Georgia, United States
🇺🇸
Georgia Pediatric Pulmonology Associates/ CHOA, Atlanta, Georgia, United States

Nefazodone in the Treatment of Social Phobia

Phase 4

Completed

Conditions: Social Anxiety Disorder (SAD)

First Posted Date: 2005-10-04

Last Posted Date: 2013-11-13

Lead Sponsor: Emory University

Target Recruit Count: 24

Registration Number: NCT00231348

Locations: 🇺🇸
Emory University Depatment of Psychiatry and Behavioral Sciences, Atlanta, Georgia, United States

Measure of Cerebrospinal Fluid (CSF) Pressure Variation With Patient Positioning

Not Applicable

Withdrawn

Conditions: Back Pain

First Posted Date: 2005-10-04

Last Posted Date: 2014-01-09

Lead Sponsor: Emory University

Registration Number: NCT00231374

Locations: 🇺🇸
Emory Orthopaedics & Spine Center, Atlanta, Georgia, United States

Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)

Not Applicable

Completed

Conditions: Hematologic Diseases
Hematologic Malignancies

Interventions: Drug: Granulocyte Colony Stimulating Factor

First Posted Date: 2005-10-04

Last Posted Date: 2014-08-22

Lead Sponsor: Emory University

Target Recruit Count: 10

Registration Number: NCT00231309

Locations: 🇺🇸
Children's Healthcare of Atlanta/Emory University, Atlanta, Georgia, United States

Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia

Phase 4

Completed

Conditions: Schizophrenia
Schizoaffective Disorder

First Posted Date: 2005-10-04

Last Posted Date: 2010-12-07

Lead Sponsor: Emory University

Target Recruit Count: 30

Registration Number: NCT00231335

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy